Man Xing
Overview
Explore the profile of Man Xing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Z, Cai L, Xing M, Qiao N, Liu J, Li X, et al.
Biosaf Health
. 2025 Mar;
6(3):153-164.
PMID: 40078728
Inactivated coronavirus disease 2019 (COVID-19) vaccines such as CoronaVac and BBIBP-CorV have been widely used in China. However, more investigation is still needed to understand antibodies' duration and effectiveness against...
2.
Niu Y, Yan Y, Hu Y, Yang X, Shi H, Zhou P, et al.
Vaccine
. 2025 Mar;
53:126959.
PMID: 40023902
Highly effective and broad-spectrum influenza vaccines are urgently required to prevent influenza outbreaks. Hemagglutinin (HA), M2 ectodomain (M2e), and nucleoprotein (NP) are crucial target antigens for the development of universal...
3.
Li Y, Ren H, Li H, Xing M, Cao J
Int J Biol Macromol
. 2024 Nov;
284(Pt 1):138081.
PMID: 39603285
Metabolic syndromes including atherosclerosis, diabetes, obesity, and hypertension are increasingly prevalent worldwide. The disorders are the primary attributes of oxidative stress and inflammation. The transient receptor potential M2 (TRPM2) channel...
4.
Dai W, Xing M, Sun L, Lv L, Wang X, Wang Y, et al.
J Virol
. 2024 Nov;
98(12):e0169924.
PMID: 39494905
Norovirus (NoV) virus-like particles (VLPs) adjuvanted with aluminum hydroxide (Alum) are common vaccine candidates in clinical studies. Alum adjuvants usually inefficiently assist recombinant proteins to induce cellular immune responses. Thus,...
5.
Wang Y, Wang Q, He F, Qiao N, Li X, Wei L, et al.
Clin Immunol
. 2024 Jul;
266:110329.
PMID: 39067679
Overwhelming evidence has shown that aging is a significant risk factor for COVID-19-related hospitalizations, death and other adverse health outcomes. Particular T cell subsets that susceptible to aging and associated...
6.
Dou W, Tong P, Xing M, Liu J, Hu X, James T, et al.
J Am Chem Soc
. 2024 Jul;
146(30):21017-21024.
PMID: 39029108
The devastating COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made society acutely aware of the urgency in developing effective techniques to timely monitor the outbreak...
7.
Jiang Y, Sun L, Qiao N, Wang X, Zhu C, Xing M, et al.
Virol Sin
. 2024 Jul;
39(4):675-684.
PMID: 38997087
Norovirus (NoV) infection is a major cause of gastroenteritis worldwide. The virus poses great challenges in developing vaccines with broad immune protection due to its genetic and antigenic diversity. To...
8.
Bai T, Cui B, Xing M, Chen S, Zhu Y, Lin D, et al.
Gene Ther
. 2024 Jul;
31(9-10):511-523.
PMID: 38961279
Neovascular age-related macular degeneration (nAMD) causes severe visual impairment. Pigment epithelium-derived factor (PEDF), soluble CD59 (sCD59), and soluble fms-like tyrosine kinase-1 (sFLT-1) are potential therapeutic agents for nAMD, which target...
9.
Gan Y, Zhang H, Liu J, He F, Li F, Li A, et al.
J Funct Biomater
. 2024 Mar;
15(3).
PMID: 38535251
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused the COVID-19 pandemic, impacting the global economy and medical system due to its fast spread and extremely high infectivity. Efficient control...
10.
Xing M, Hu G, Wang X, Wang Y, He F, Dai W, et al.
NPJ Vaccines
. 2024 Mar;
9(1):64.
PMID: 38509167
Despite prolonged surveillance and interventions, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses continue to pose a severe global health burden. Thus, we developed a chimpanzee adenovirus-based...